TECHNOLOGY SUMMARY
Neurovation Labs, Inc. is developing the first-ever objective diagnostic and companion precision medication for Post-traumatic Stress Disorder (PTSD) based on a groundbreaking brain biomarker discovery. PTSD is frequently diagnosed in both military as well as civilians after exposure to trauma. Neurovation Labs is transforming mental healthcare from art to science.
AREA/MATURITY/AWARDS
Primary Application Area: Biotech, Pharma, Health
Technology Development Status: Prototype
Technology Readiness Level: TRL 4
SHOWCASE SUMMARY
Organization Type: Early-stage Startup (Seed)
Website: http://www.neurovationlabs.com
MARKET KEYWORDS
Market Keywords: first-in-class, rapid diagnosis, precision treatment